Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 3
1966 1
1968 1
1969 3
1970 2
1971 1
1972 3
1973 1
1974 1
1975 1
1979 1
1980 1
1981 3
1982 3
1983 1
1984 2
1985 1
1986 2
1987 1
1988 5
1989 3
1990 6
1991 7
1992 5
1993 6
1994 2
1995 2
1996 4
1997 6
1998 5
1999 4
2000 1
2001 5
2002 11
2003 11
2004 6
2005 3
2006 1
2007 3
2008 6
2009 3
2010 6
2011 9
2012 5
2013 5
2014 8
2015 5
2016 6
2017 6
2018 11
2019 8
2020 14
2021 13
2022 15
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Yamaguchi K; DESTINY-Gastric01 Investigators. Shitara K, et al. Among authors: kamio t. N Engl J Med. 2020 Jun 18;382(25):2419-2430. doi: 10.1056/NEJMoa2004413. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469182 Clinical Trial.
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.
Yamaguchi K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Shimoyama T, Lee KW, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Shitara K. Yamaguchi K, et al. Among authors: kamio t. J Clin Oncol. 2023 Feb 1;41(4):816-825. doi: 10.1200/JCO.22.00575. Epub 2022 Nov 15. J Clin Oncol. 2023. PMID: 36379002 Free PMC article. Clinical Trial.
Response to RMED-D-22-00,258.R1.
Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, Kasahara K, Ogawa T, Kato H, Hase R, Kashizaki F, Nishi K, Kamio T, Mitamura K, Ikeda N, Nakagawa A, Fujisawa Y, Taniguchi A, Ikeda H, Hattori H, Murayama K, Toyama H. Ohno Y, et al. Among authors: kamio t. Jpn J Radiol. 2022 Aug;40(8):860-861. doi: 10.1007/s11604-022-01308-8. Epub 2022 Jun 25. Jpn J Radiol. 2022. PMID: 35751793 Free PMC article. No abstract available.
The taxonomy of the bovine Theileria spp.
Fujisaki K, Kawazu S, Kamio T. Fujisaki K, et al. Among authors: kamio t. Parasitol Today. 1994 Jan;10(1):31-3. doi: 10.1016/0169-4758(94)90355-7. Parasitol Today. 1994. PMID: 15275565
Strongyloidiasis.
Asano K, Tada S, Kamio T, Matsumoto T, Suko H, Iida M. Asano K, et al. Among authors: kamio t. Gastrointest Endosc. 2004 Oct;60(4):606-7. doi: 10.1016/s0016-5107(04)01861-9. Gastrointest Endosc. 2004. PMID: 15472693 No abstract available.
Gastric syphilis.
Yoshida K, Tada S, Ueno N, Owan T, Suko H, Kamio T, Matsumoto T. Yoshida K, et al. Among authors: kamio t. Gastrointest Endosc. 2003 Dec;58(6):908-9. doi: 10.1016/s0016-5107(03)02295-8. Gastrointest Endosc. 2003. PMID: 14652561 No abstract available.
Ileal adenoma.
Ohwan T, Tada S, Ueno N, Gohda K, Uehara M, Suko H, Kamio T, Matsumoto T. Ohwan T, et al. Among authors: kamio t. Gastrointest Endosc. 2003 Jan;57(1):98. doi: 10.1067/mge.2003.6. Gastrointest Endosc. 2003. PMID: 12518141 No abstract available.
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
Shitara K, Yamaguchi K, Muro K, Yasui H, Sakai D, Oshima T, Fujimura M, Sato Y, Yamazaki S, Wakabayashi T, Sugihara M, Kamio T, Shoji H. Shitara K, et al. Among authors: kamio t. Int J Clin Oncol. 2024 Jan;29(1):27-35. doi: 10.1007/s10147-023-02422-x. Epub 2023 Nov 14. Int J Clin Oncol. 2024. PMID: 37964066 Free PMC article.
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast Cancer.
Shimomura A, Takano T, Takahashi S, Sagara Y, Watanabe J, Tokunaga E, Shinkai T, Kamio T, Kikumori K, Kamiyama E, Fujisaki Y, Saotome D, Yamashita T. Shimomura A, et al. Among authors: kamio t. Clin Pharmacol Ther. 2023 Jan;113(1):160-169. doi: 10.1002/cpt.2757. Epub 2022 Oct 18. Clin Pharmacol Ther. 2023. PMID: 36164935 Free PMC article.
248 results